Structural and functional changes of cardiovascular system in primary hypothyroidism co-existent with hypertension
https://doi.org/10.18705/1607-419X-2015-21-4-403-408
Abstract
Objective. To analyze relationship between thyroid status and target organ damage system in patients with arterial hypertension in combination with primary hypothyroidism (subclinical and compensated).
Design and methods. We enrolled 42 women with primary hypothyroidism and concomitant hypertension aged from 50 to 75 years old. Patients were divided into two comparable groups, the first group included 24 hypertensive patients with subclinical hypothyroidism, the second group included 18 hypertensive patients with compensated hypothyroidism. All patients underwent echocardiography and assessment of endothelial function. Lipids were measured in all patients.
Results. Target organ damage, including left ventricular hypertrophy, left ventricular diastolic dysfunction, and endothelial dysfunction were comparable in both groups. The associations between thyrotrophic hormone and the levels of cholesterol and triglycerides were also similarin both groups.
Conclusions. Subclinical hypothyroidism is neither associated with worsening of hypertension-related target organ damage, nor affects significantly lipid profile.
About the Author
A. V. NikolaevaRussian Federation
MD, PhD, Professor Assistant, Department of Internal Diseases in Outpatient Setting with the Courses of Clinical Pharmacology and Preventive Medicine,
281, Kommunarov street, Izhevsk, 426034
References
1. Somwaru LL, Rariy CM, Arnold AM, Cappola AR. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab. 2012;97 (6):1962–1969.
2. Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DC, Luben R et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol. 2010;72(3):404–410.
3. Dernellis J, Panaretou M. Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism. Am Heart J. 2002;143(4):718–724.
4. Моргунова Т.Б., Мануйлова Ю.А., Фадеев В.В. Медико-социальные аспекты заместительной терапии гипотиреоза: факторы, влияющие на качество компенсации. Клиническая и экспериментальная тиреоидология. 2007;3:12–24. [Morgunova TB, Manuilova YuA, Fadeev VV. Medical and social issues of hormonal therapy in hypothyroidism: factors affecting compensation. Klinicheskaya i Eksperimentalnaya Tireoidologiya = Clinical and Experimental Thyroidology. 2007;3:12–24. In Russian].
5. Yazici M, Gorgulu S, Sertbas Y, Erbilen E, Albayrak S, Yildiz O et al. Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function. Int J Cardiol. 2004;95(2–3):135–143.
6. Clausen P, Mersebach H, Nielsen B, Feldt-Rasmussen B, Feldt-Rasmussen U. Hypothyroidism is associated with signs of endothelial dysfunction despite 1-year replacement therapy with levothyroxine. Clin. Endocrinol. 2009;70(6):932–937.
7. Leeson P, Augustine D, Mitchell A RJ, Becher H. Echocardiography. Oxford Specialist Handbooks in Cardiology. Second Edition. 2012. p. 174–178.
8. Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. J Am Coll Cardiol. 2008;52(14):1152–1159.
9. Turner MR, Camacho X, Fischer HD, Austin PC, Anderson GM, Rochon PA et al. Levothyroxine dose and risk of fractures in older adults: nested case-control study. Br Med J. 2011;342: d2238.
Review
For citations:
Nikolaeva A.V. Structural and functional changes of cardiovascular system in primary hypothyroidism co-existent with hypertension. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2015;21(4):403-408. (In Russ.) https://doi.org/10.18705/1607-419X-2015-21-4-403-408